课题基金 / 基金详情

Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer

Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
非编码 RNA 作为前列腺癌的预后和诊断标志物
批准号:
10014478
负责人:
Stefan Ambs
金额:
$9.5万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Stefan Ambs的其他基金

相似基金

相关文献

中文摘要
翻译
在本项目中,我们一直在探索两个microRNAs,miR-484和mir-769的功能。在我们以前的研究中,我们发现mir-484与前列腺外扩散有关,进一步的分析表明miR-484与降低无复发生存率显著相关。其他实验表明,miR-484的表达增加了前列腺癌细胞的迁移。人们对这种微小RNA的功能知之甚少。它是线粒体生物发生的调节器。对TargetScan预测的靶基因的通路分析表明,该microRNA可能调节新陈代谢。对这些预测函数进行了研究。此外,我们还研究了mir-769的功能及其在人前列腺癌细胞迁移和侵袭中的作用。对这两个微小RNA的研究已经完成,该项目于2019年停止。已经提交了描述miR-484功能的手稿。
英文摘要
In this project, we have been exploring the function of two microRNAs, miR-484 and mir-769. In our previous studies, we identified mir-484 as being associated with extraprostatic extension and further analyses revealed that miR-484 significantly associates with reduced recurrence-free survival. Additional experiments showed that miR-484 expression increases migration of prostate cancer cells. There is not much known about the function of this microRNA. It is a regulator of mitochondrial biogenesis. A pathway analysis of TargetScan-predicted target genes indicated that this microRNA may regulate metabolism. These predicted functions were investigated. Furthermore, we studied the function of mir-769 and its involvement in migration and invasion of human prostate cancer cells. Studies of these two microRNAs have been completed and the project was discontinued in 2019. A manuscript describing the function of miR-484 has been submitted.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Molecular Profile of Prostate Tumors in African-American Men
Novel Markers for Disease Outcome in Breast Cancer
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
海外基金